Regenerative Medical Technology Group Inc. — Operating Income by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/7be61e67-c0c9-4ccc-a7f5-e9535cafed50/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-867.2k | 2025-01-01 – 2025-12-31 | evidence 0001213900-26-056841 |
| FY 2024 | $81.2k | 2024-01-01 – 2024-12-31 | evidence 0001213900-25-032016 |
| FY 2023 | $-715.2k | 2023-01-01 – 2023-12-31 | evidence 0001213900-25-032016 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Regenerative Medical Technology Group Inc. — all facts · Revenue · Net Income